Podcasts about translational science

Dr. Brianna Stubbs, director of Translational Science at the Buck Institute for Research on Aging, explores the science behind ketone metabolism and its benefits for women. Learn how ketones can support your fitness goals, regulate appetite, aid in recovery, and even contribute to healthy brain aging. This episode is full of actionable insights and valuable tips for incorporating ketones into your wellness routine.KETONE-IQ Get 30% off when you Subscribe & Save at https://ketone.com/STEPHANIEEpisode Overview (timestamps are approximate):(10:00) Optimizing Performance With Ketones(23:00) Ketones and Appetite Regulation(28:00) Ketones and Muscle Protection(36:00) Ketones, Exercise, and Muscle Metabolism(43:00) Strategic Use of Ketones for Performance(48:00) Ketones for Energy and Recovery(53:00) Ketones and Cellular Aging(1:04:00) Advancing Biomarkers for Healthy Aging(1:09:00) BONUS the “After-Party” with Dr. StephanieResources mentioned in this episode acn be found at https://drstephanieestima.com/podcasts/ep422We are grateful to our sponsors:LVLUP - Midlife hormonal changes can wreak havoc on your gut health. Ultimate GI Repair combines powerful gut-healing peptides with gut-nourishing naturals to soothe your changing digestion. Learn more at https://lvluphealth.com/DRSTEPHANIE and use code DRSTEPHANIE for 15% offONESKIN - Harness the power of peptides for fuller hair and glowing skin. Save 15% at https://oneskin.co/better with code BETTER.EQUIP COLLAGEN - Support bones, joints, gut, and skin with Equip Collagen. Get 20% off at https://equipfoods.com/better with code BETTER.LMNT - Rehydrate with the perfect mix of sodium, potassium, and magnesium. Get a free sample pack at https://drinklmnt.com/drestima.

Our guest this week, Lara Campana is SVP of Research & Translational Science and a co-founder of Resolution Therapeutics, a company developing regenerative macrophage therapies for inflammatory and fibrotic diseases. In this episode of Careers in Discovery, Lara shares her journey from medical Biotechnology student in Milan to Biotech executive in the UK, and why she's been fascinated by macrophages ever since a single line in a university lecture hinted at their regenerative potential. We talk about the origins of Resolution, how the company grew from a trio of postdocs in a university lab to a clinical-stage Biotech, and the challenges of leading teams, building culture, and letting go as a founder. Lara also reflects on the mindset shift from academic research to pragmatic, patient-focused drug development - and the lessons she's learned along the way about influence, resilience, and finding space to think.

Listen and learn from expert insights on a variety of topics at the Association for Clinical & Translational Science (ACTS) conference in our nation's capitol. We're taking our show on the road…and you're coming with us…inside this special edition of CTSI Discovery Radio!

In this episode of Ageless Athlete, we dive into the metabolic engine room with Dr. Brianna Stubbs—world-class endurance athlete and leading researcher at the Buck Institute for Research on Aging. Brianna bridges the worlds of elite performance and cutting-edge science, specializing in how ketones, fasting, and metabolic flexibility can shape our ability to recover, sustain energy, and age well.This isn't about dieting fads or silver bullets—it's about understanding how your body fuels itself, and how those energy pathways evolve over time. Whether you're an endurance athlete or someone simply trying to stay strong into your 40s, 50s, and beyond, Brianna's insights will give you a fresh way to think about performance and longevity.

How can Continuous Glucose Monitoring (CGM) help people with type 2 diabetes feel more empowered and in control of their health? Exploring compelling new research presented at the Advanced Technologies & Treatments for Diabetes (ATTD) conference is host Cher Pastore, MS, RD, CDCES, BC-ADM, and guest Sim Singh, Senior Director of Behavioral and Translational Science at Dexcom. Together, they unpack findings from a 30-day study of Dexcom G7 use in people with type 2 diabetes, including those not on insulin. The results show significant improvements in glucose tracking, behavioral shifts like better nutrition and increased physical activity, and enhanced metabolic health and confidence - especially among CGM-naive users. Sim also shares insights from a Canadian trial and discusses how CGM is transforming diabetes education, not only for patients but for endocrinologists and primary care providers as well. Whether it's supporting blood sugar monitoring, enabling personalized diabetes treatment, or simply helping people better understand their glucose patterns, this conversation highlights how CGM and biosensor technology are reshaping diabetes management - for people with type 1 diabetes, type 2 diabetes, and even prediabetes.

Dual-PhD researcher Celeste Beck is a leading maternal health researcher at Heluna Health who just published a groundbreaking study on vitamin D and pregnancy.It turns out something as simple as your vitamin D levels could have a major impact on your pregnancy, postpartum recovery, and your baby's health. With over 15 years in public health and a dual PhD in Nutritional Science and Clinical and Translational Science, Celeste breaks down what every parent needs to know—how to recognize the risks of deficiency, when and how to supplement, and why this one nutrient can make a lifelong difference for your baby.If you're pregnant, postpartum, or supporting someone who is, this episode gives you the critical info your doctor might not be talking about - yet. Advocating for yourself with the right information empowers you and gives your baby the healthiest start possible.Full show notes fourthtrimesterpodcast.comConnect with Celeste Beck PhD LinkedInCeleste's research in the American Journal of Clinical Nutrition Maternal vitamin D status, fetal growth patterns, and adverse pregnancy outcomes in a multisite prospective pregnancy cohortLearn more Evidence Based Care for Improving Postpartum Recovery - Advice From Dr Rebecca Dekker | Morning Sickness Causes and Cures: Hyperemesis Genetic Link and Practical Advice from USC Geneticist Dr Marlena FejzoResources HelloGaia Parenting Copilot | FREE DOWNLOAD Customizable Birth Plan | FREE DOWNLOAD Customizable Fourth Trimester PlanConnect with Fourth Trimester Facebook | InstagramWant trustworthy parenting data at your fingertips? Download HelloGaia Parenting Copilot for FREE today. The app uses reliable sources like ACOG, AAP, The Society for Maternal-Fetal Medicine. FREE app available now on Apple & Google Play

Gugs Mhlungu speaks to Scientific Director of the HIV Pathogenesis Programme and a Professor in HIV/TB Research at the University of KwaZulu-Natal, Prof Thumbi Ndung’u on what to make of their groundbreaking study which aims to reduce reliance on ART for HIV patients. Professor Thumbi Ndung'u is the Scientific Director of the HIV Pathogenesis Programme and a Professor in HIV/TB Research at the University of KwaZulu-Natal. He is the Director for Basic and Translational Science at the Africa Health Research Institute (AHRI), a Professor of Infectious Diseases at University College London. He is the Programme Director of the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a research and capacity building initiative. See omnystudio.com/listener for privacy information.

Send us a textDr. Peter Ordentlich, Ph.D. is Chief Scientific Officer and Founder, Syndax Pharmaceuticals ( https://syndax.com/team/peter-ordentlich-ph-d/ ), a company with a mission to obtain regulatory approval and commercialize drugs that extend and improve the lives of cancer patients, by drawing on the newest scientific research and advances, collaborating with determined problem solvers, and identifying value in overlooked aspects of science.Dr. Ordentlich co-founded the Company in October 2005 and has served as Chief Scientific Officer since September 2016.Dr. Ordentlich previously served as Syndax's Chief Technical Officer, Vice President, Translational Medicine, Executive Director, Translational Science, and Director, Scientific Affairs and Strategic Alliances.Prior to founding the company, Dr. Ordentlich was a scientist at the Salk Institute for Biological Studies, a biological research non-profit organization. He also spent five years as a research scientist at X-Ceptor Therapeutics, Inc., a drug discovery company, which was acquired by Exelixis, Inc.Dr. Ordentlich received a B.A. in Biochemistry and a Ph.D. in Immunology from the University of Pennsylvania.#PeterOrdentlich #SyndaxPharmaceuticals #Oncology #Cancer #Menin #KMT2Ar #AcuteLeukemias #NPM1m #AcuteMyeloidLeukemia #Revuforj #Niktimvo #Axatilimab #Revumenib #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast #STEM #Innovation #Science #Technology #ResearchSupport the show

What is translational science? How is AI used in healthcare? What is JAMA+ AI in medicine? How long does it take to publish a study in JAMA? How many journals does JAMA publish? JAMA® Editor-in-Chief Kirsten Bibbins-Domingo, MD, PhD, discusses her priorities for JAMA this year, the launch of JAMA+ AI and Translational Science Reviews, and what's still to come in 2025. American Medical Association CXO Todd Unger hosts.

In this Review Series episode on Basic/Translational Science of Factor VIII, Factor IX, and von Willebrand Factor introduced by Dr. Thomas Ortel, we'll hear from contributing authors Drs. Ben Samuelson Jones, Mac Monroe and Peter Lenting as they discuss how the functional roles of these 3 proteins are interconnected. Click here to view the complete Review Series featured in Volume 144 Issue 21 of Blood.

LEXINGTON, Ky. (Feb. 14, 2025) – It seems like foreshadowing that they met while playing the board game Life. Marietta Barton was 19 years old; Jeff Baxter was 21. Despite both growing up in London, Ky., they never crossed paths until they moved to Lexington for college. But within a few weeks of their chance meeting, they were in love—and engaged.   Now, 35 years into their marriage, Jeff has published a book chronicling their whirlwind romance, the life-altering health struggles they faced soon after, and their enduring commitment to one another.   He originally wrote the book, “Ten Dates Later: The Story of an MS Caregiver,” as a surprise gift for Marietta (now Barton-Baxter) in 2023. But after sharing the text with a few friends, they were encouraged to publish it to help others facing the challenges of chronic illness and caregiving. They also decided to donate the proceeds from the book to multiple sclerosis research at the University of Kentucky, where they both earned their degrees, and where Marietta has worked in health research for 37 years. She currently serves as the regulatory program director and biobank project director in the Center for Clinical and Translational Science. Jeff recently retired after serving for 28 years as a physical education teacher in the Fayette County Public Schools.  On this episode of Behind the Blue, Jeff and Marietta tell their story, which is inextricably intertwined with the University of Kentucky; from the beginnings of their romance, to their college educations, to the diagnoses and care for both of them, and to Marietta's impactful 37-year career in health research at UK.

SpaceTime Series 28 Episode 10Gaia's Sky Scanning Completion and Mid Infrared Flare from Sagittarius A*The European Space Agency's Gaia spacecraft has completed its sky scanning phase, marking a monumental achievement in astronomical missions. Over the past decade, Gaia has transformed our understanding of the Milky Way by mapping the positions and characteristics of billions of stars. This mission has provided unprecedented insights into the origins and evolution of our galaxy, revealing its structure and history like never before.Mid Infrared Flare from the Milky Way's Supermassive Black HoleAstronomers have detected a mid infrared flare from Sagittarius A*, the supermassive black hole at the center of the Milky Way. This discovery, made using NASA's Webb Space Telescope, fills a crucial gap in our understanding of black hole flares and supports existing models of magnetic reconnection in the accretion disk surrounding the black hole.Discovery of a New Type of ExoplanetNASA's Webb Space Telescope has unveiled a new type of exoplanet, unlike anything in our solar system. The planet, GJ1214B, exhibits a carbon dioxide-rich atmosphere similar to Venus, challenging previous assumptions about exoplanet atmospheres and providing new insights into planetary formation.00:00 This is space time series 28 episode 10 for broadcast of 22 January 202500:49 European Space Agency's Gaia spacecraft has completed its 10th science mission05:22 First ever detection of mid infrared flare from Milky Way's supermassive black hole11:15 NASA's Webb Space Telescope has discovered a new type of planet14:11 New study suggests eating carrots can improve the treatment of type 2 diabetes17:41 Tesla is launching satellite connectivity for regular mobile phones in Australiawww.spacetimewithstuartgary.comwww.bitesz.com

University at Buffalo announces a $28.4 million CTSA grant from the NIH to build on strong foundation improving health outcomes and addressing disparities through translational science full 2138 Fri, 17 Jan 2025 15:00:46 +0000 WhCdvSrXSCwTlAY0n5NwPWOrBmPskGQ3 buffalo,news,wben,university at buffalo,sean ryan,tim kennedy,ub jacobs school of medicine and biomedical sciences WBEN Extras buffalo,news,wben,university at buffalo,sean ryan,tim kennedy,ub jacobs school of medicine and biomedical sciences University at Buffalo announces a $28.4 million CTSA grant from the NIH to build on strong foundation improving health outcomes and addressing disparities through translational science Archive of various reports and news events 2024 © 2021 Audacy, Inc.

In a conversation with CancerNetwork® during Pancreatic Cancer Awareness Month, Tanios S. Bekaii-Saab, MD, spoke about various developments in the pancreatic cancer treatment field. Throughout the discussion, Bekaii-Saab weighed the benefits of currently available chemotherapeutic regimens for patients with metastatic disease, discussed research on the potential for precision medicine in those with KRAS wildtype pancreatic ductal adenocarcinoma (PDAC), and detailed ongoing initiatives to improve outcomes among those with RAS mutations and other targetable genomic alterations. Bekaii-Saab is the David F. and Margaret T. Grohne Professor of Novel Therapeutics for Cancer Research, chair and consultant in the Division of Hematology and Medical Oncology at Mayo Clinic in Arizona, and co-leader of Advanced Clinical and Translational Science at Mayo Clinic Cancer Center. Given the prevalence of RAS mutations and other alterations in patients with pancreatic cancer, Bekaii-Saab especially emphasized the use of genomic analysis to inform personalized treatment decision-making in the field. Screening patients to detect aberrations such as microsatellite instability-high tumors, BRAF 600E mutations, KRAS G12C mutations, and NRG1 fusions can open the door for the development and use of targeted agents, which may consequently improve patient outcomes.  Looking ahead, Bekaii-Saab noted the need to adapt the therapies that have shown activity in the later stages of the disease to earlier treatment settings. Although “great work” has been achieved with chemotherapy and surgical techniques, he highlighted the importance of bringing targeted agents to earlier lines of therapy to further increase the likelihood of positive outcomes for patients.  “I have never been more optimistic. I'm always the eternal optimist, but I'm even more optimistic today that we're going to move the needle for our patients with pancreatic cancer and continue to enhance that likelihood of living longer, having a better quality of life, or even increasing the level of a cure for this cancer,” Bekaii-Sabb stated. “Certainly, the future looks bright. We're chipping away, one drug at a time. We can now remove that whole concept of nihilism in pancreatic cancer and look quite optimistically on the future.”

"Translational science is really general principles for how we take scientific discoveries and basic scientific information and translate that into implementable, viable, feasible health solutions for both the patient and the provider to be able to utilize," says Michael Kurilla, MD, PhD, of the National Center for Advancing Translational Sciences (NCATS). In this episode, Kurilla discusses his work as the director of the Division of Clinical Innovation at NCATS, and the role translational research and science plays in healthcare. Harvard Catalyst is a member of the NCATS Clinical and Translational Science Awards (CTSA) Program. Transcript: https://bit.ly/3OeJta1

In this episode of Careers in Discovery I sit down with Simon Young, VP of Translational Science at C4X Discovery. Simon's career has taken some fascinating twists and turns, from veterinary medicine to electrical engineering, and eventually into diagnostics, drug discovery and precision medicine. He shares how those experiences have shaped his approach today, and how staying flexible, taking on new challenges and stepping out of your comfort zone have helped him to build an exciting career.

In this edition of Clinical Lab Chat, CLP's Director of Business Intelligence, Chris Wolski, interviews Alessio Travaglia, PhD, PMP, director, Translational Science, Neuroscience, at the Foundation for the National Institutes of Health (FNIH). The wide-ranging interview tackles all aspects of Alzheimer's testing and treatment, including:Why traditional methods of Alzheimer's testing are expensive, invasive, and limit access.The benefits of blood-based biomarkers for Alzheimer's diagnosis.How better diagnostics will benefit patients.Why we're on the cusp of a new golden age of neurologyHow more biomarkers fuel not only better diagnostics but better treatments.

Send us a Text Message.Prof. Dr. Alan Widgerow, MBBCh, FCS, MMed, FACS, is Division Chief, Research, Center for Tissue Engineering ( https://sites.uci.edu/ctelab/team/ ) and Adjunct Professor Plastic Surgery, Dept of Plastic Surgery, University of California, Irvine ( https://faculty.uci.edu/profile/?facultyId=6048 ) and Chief Scientific Officer and Head of Skin Science Center of Innovation at Galderma ( https://www.galderma.com/ ).Prof. Widgerow is a plastic surgeon who ran a solo private practice in South Africa for over 20 years. Prof. Widgerow completed his undergraduate and post-graduate studies at the University of the Witwatersrand, South Africa. He has held various positions in numerous academic and professional associations including that of President of the Association of Plastic and Reconstructive surgery of Southern Africa (APRSSA). He is author of over 190 plastic surgical related publications and 2 books. He was also the founder and medical director of 13 wound clinics in South Africa. Prof. Widgerow relocated to Irvine California in Dec 2009 to pursue his interests in medical device innovations, cosmeceuticals and wound care, but he still plays an active role in academic medicine world-wide. In 2012 he was appointed to the Faculty of the University of California Irvine Plastic Surgery Dept as Full Adjunct Professor and Director of the Center for Tissue Engineering and in 2021 was appointed as its Division Chief of Research. He is involved in multiple projects related to adipose derived stem cell and adipose decellularized matrix, wound healing and transplantation. In 2018 he was awarded the Distinguished Faculty Mentor of the year Award by the Institute for Clinical and Translational Science, UCI. Prof. Widgerow has developed and licensed multiple products in the US and South African markets. In 2015 he joined ALASTIN Skincare, Inc. an early start up professional skin care company as their Chief Medical Officer. Over the past 6 years he has spearheaded the scientific innovations team introducing multiple new products based on novel wound healing pathways. The resulting products have been validated with gene expression, in vitro and ex-vivo testing, biopsies, and multiple clinical trials resulting in a range of products that have surpassed previous scientific validations in this space. He continues to pursue patented novel concepts, peptide technologies and vigorous testing thus contributing to Alastin Skincare's position as the fastest growing professional skin care company in the US for the past 4 years. In 2021, Alastin Skincare was acquired by Galderma, the largest privately owned dermatology company in the world, and in June 2022, Prof. Widgerow was appointed Chief Scientific Officer of Galderma, Head of the Skin Science Center for Innovation and Head of Alastin innovations. He is involved in aesthetic, prescription and consumer product science research and development.#AlanWidgerow #CenterForTissueEngineering #PlasticSurgery #UniversityOfCalifornia #Irvine #ChiefScientificOfficer #SkinScience #Galderma #Dermatology #ExtracellularMatrix #StemCells #Exosomes #ECM #Aging #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast  #STEM #Innovation #Technology #Science #ResearchSupport the Show.

LEXINGTON, Ky. (August 1, 2024) – Katherine Hartmann, M.D., Ph.D., is the new director of the University of Kentucky's Center for Clinical and Translational Science (CCTS). Hartmann is an obstetrician-gynecologist (OB-GYN), epidemiologist and health services researcher, in addition to leading the UK CCTS.  She graduated from University of North Carolina at Chapel Hill's epidemiology Ph.D. program and Johns Hopkins University's M.D. program. Hartmann comes to UK from Vanderbilt University where she recently served as associate dean for clinical translational scientist development. As a physician scientist, Hartmann has years of expertise with research involving large community-recruited cohorts, behavioral interventions and clinical trials. Her work includes groundbreaking results that have answered key questions for women's health during pregnancy.  Asking questions and finding answers is what initially sparked her interested in health research. Her goal is to improve the quality of health care for all people — a goal that aligns with the UK CCTS. The mission of the UK CCTS is to accelerate discoveries to improve health through a multi-faceted approach to support research from bench to bedside to community.  Hartmann said the reach of the University of Kentucky and the teamwork between disciplines to find answers to pressing health questions is why she was drawn to Lexington.   Learn more about her research and her goals while leading the UK CCTS on this episode of “Behind the Blue.” "Behind the Blue" is available on iTunes, Google Play, Stitcher and Spotify. Become a subscriber to receive new episodes of “Behind the Blue” each week. UK's latest medical breakthroughs, research, artists and writers will be featured, along with the most important news impacting the university. For questions or comments about this or any other episode of "Behind the Blue," email BehindTheBlue@uky.edu or tweet your question with #BehindTheBlue. Transcripts for this or other episodes of Behind the Blue can be downloaded from the show's blog page.  To discover what's wildly possible at the University of Kentucky, click here.

Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research interview Louise Ross from the National Centre for Smoking Cessation and Training (NCSCT). Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Louise Ross from the National Centre for Smoking Cessation and Training (NCSCT). Louise Ross has worked in smoking cessation for over 20 years and consults for the NCSCT, and is part of the senior team on the Smoke Free App, a digital service for helping people stop smoking. NCSCT is a social enterprise committed to supporting the delivery of effective evidence-based tobacco control programmes and smoking cessation interventions provided by local stop smoking services, and by colleagues in the NHS and the social care sector. For further information about NSCST: https://www.ncsct.co.uk/ Louise Ross talks about the swap to stop scheme that aimed to reach a million people who smoke to give them a chance to switch less harmful vapes. The swap to stop training is not only for qualified stop smoking practitioners but is also aimed at the frontline services working with for example debt management teams within social housing, homelessness, substance use, and other groups. The training models how to raise the subject of quitting smoking and swap to stop. A four week supply of e-liquid is provided and, if funds are available, a 12 week supply. People are advised how much they should use their vape and to use an e-liquid that is strong enough to manage their withdrawal symptoms, as they would be with nicotine replacement therapy. They are also advised not to stop using a vape too soon as they may go back to tobacco smoking. Jamie and Nicola discuss ongoing work on brief opportunistic advice in financial support settings. The scoping review mentioned is available here: https://onlinelibrary.wiley.com/doi/full/10.1111/add.16533 This podcast is a companion to the electronic cigarettes Cochrane living systematic review and shares the evidence from the monthly searches. Our literature searches carried out on 1st June found: One linked study: Leavens E.; Nollen N, Ahluwalia J, Mayo M, Rice M, Brett E, Pulvers K. Changes in dependence, withdrawal, and craving among adult smokers who switch to nicotine salt pod-based e-cigarettes, Journal of Clinical and Translational Science / 2021;5(Supplement 1):85-86, DOI: 10.1017/cts.2021.622 For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review updated in January 2024 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub8/full This podcast is supported by Cancer Research UK.

To learn more about the Chief Medical Officer Summit 360° and its associated editorials, podcasts and webcasts, please visit CMO360.org

Title: What is Paroxysmal Sympathetic Hyperactivity?  Target Audience This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards. Objectives: Upon completion of this activity, participants should be able to: 1.    Review the name changes that have occurred for Paroxysmal Sympathetic Hyperactivity (PSH). 2.       Review the current definition and symptomatology of PSH. 3.       Review treatment and management of PSH. Faculty:  Planning Committee: Allison Williams MD, — Assistant Professor of Pediatrics, Division of Pediatric Hospital Medicine, UPMC Children's Hospital of Pittsburgh   Course Directors: Tony R. Tarchichi MD — Associate Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Division of Pediatric Hospital Medicine Dr. Tarchichi has disclosed he was a member of the Advisory Board for meningococcal vaccine in immunocompromised patient for Sanofi Corp Scott H. Maurer, MD, FAAHPM—  Professor, Department of Pediatrics & Clinical and Translational Science, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.).  Hitoshi Koshiya MD - Post Graduate Year Five Child Neurology Fellow, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.).    Conflict of Interest Disclosure: No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.   Accreditation Statement: In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.   The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.   Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.   Disclaimer Statement: The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.   Released 5/23/2024,  Expires 5/24/2027   The direct link to the course is provided below: Pediatric Hospital Medicine: Updates in Urinary Tract Infections - PHM Podcast series COMING SOON!!

The Childhood Vaccine Schedule and Covid Vaccine Injury Presentation and Webinar. Dr. Peter McCullough, Professor Brian Hooker, Ph.D,  Senator Ron Johnson, Dr. Scott Mitchell, Dr. Ryan Cole and Dr. Kirk A Milhoan. Dr. McCullough Delivers Message All Parents Need to Hear “This childhood vaccine schedule is not what we thought... I'm telling you, in total, it doesn't look good.” The 1986 Vaccine Injury Act even admits vaccines come with “unavoidable harms.” Five separate studies now show that “if children go natural, no vaccines whatsoever, they have the best outcomes.” “When I was a kid, the rate of autism was one in 10,000. Now it's one in 36,” @P_McCulloughMD explained. “And there's about 200 published manuscripts showing it's immune system dysregulation.” “And the vignettes, the mothers tell us that the child was fine up until the time they took multiple rounds of vaccines, and then they developed autism. Those vignettes are almost certainly correct. We can't pin it down to any single vaccine. But I'm telling you, in total, it doesn't look good. This epidemic of autism is a tsunami. And you know how many, many mothers now — [a] recent Kaiser Family Foundation survey shows about a third of mothers and young fathers going natural.”   The Vigilant Fox  “The CDC has never looked at long-term health outcomes of vaccinated versus unvaccinated children,” attested Professor Brian Hooker, Ph.D., during a presentation to the World Council of Health. Brian Hooker is senior director of science and research at Children's Health Defense and professor emeritus of biology at Simpson University in Redding, California, who has been doing advocacy and research around vaccine safety for 20 years. In light of the CDC's unwillingness to conduct long-term studies comparing vaccinated and unvaccinated children, Dr. Hooker took it upon himself to aggregate and conduct such studies. This is what he found. Top of Form Bottom of Form Dr. Hooker presented a study from Anthony R. Mawson and colleagues. This study collected information from moms who homeschooled their children and focused on children between the ages of 6 and 12. Link to Study Comparing the vaccinated and the unvaccinated, Mawson and colleagues discovered something stark. The odds ratios for a number of illnesses were through the roof for the vaccinated cohort. Children in the vaccinated population were found to be a staggering 30 times more likely to have allergic rhinitis compared to the unvaccinated children. A similar story followed for other conditions. Vaccinated children in Mawson's study were found to be 3.9 times more likely to have allergies, 4.2 times more likely to have ADHD, 4.2 times more likely to have autism, 2.9 times more likely to have eczema, 5.2 times more likely to have a learning disability, and 3.7 times more likely to have a neurodevelopmental disorder compared to the unvaccinated children. Dr. Mawson's research paper was initially published in the journal Frontiers in Public Health and gained considerable attention, accumulating over 80,000 views within the first three days. After widespread attention, the journal subsequently removed the paper, stating that it had never been fully accepted despite its earlier publication. The article underwent another round of peer review and was ultimately rejected by Frontiers. Undeterred by this turn of events, Dr. Mawson went on to republish his paper in the Journal of Translational Science in 2017. Critics will say, “This is just one study.” Well, Professor Brian Hooker and Democratic Presidential candidate Robert F. Kennedy Jr. have accomplished quite the feat, compiling over 100 other studies like Mawson's comparing health outcomes between vaccinated and unvaccinated children. And what they've found is quite remarkable. Unvaccinated children consistently have better health outcomes than vaccinated children. The book is called Vax-Unvax: Let the Science Speak. You can check it out here. Dr. Hooker's full presentation with the World Council for Health is available to watch here.     Covid Vaccines - The Devastating Health Crisis in the Channel Islands & Around the World CI UK Alliance 220 followers Watch the entire webinar at- NewsChannel IslandsCovid ResponseHealth ConcernsVaccine DamageExcess DeathsmRNAAndrew BridgenSenator Ron JohnsonDr Peter A McCulloughProfessor Angus Dalgleish or https://rumble.com/v4ryjyt-covid-vaccines-the-devastating-health-crisis-in-the-channel-islands-and-aro.html   Webinar recorded Friday 26th April 2024 chaired by Senator Ron Johnson with Andrew Bridgen MP and esteemed medical professionals including Dr. Peter A McCullough, Professor Angus Dalgleish, Dr. Dean Patterson, Dr. Scott Mitchell, Dr. Ryan Cole and Dr. Kirk A Milhoan.   HELP ACU SPREAD THE WORD!  Please go to Apple Podcasts and give ACU a 5 star rating. Apple canceled us and now we are clawing our way back to the top. Don't let the Leftist win. Do it now! Thanks. Also Rate us on any platform you follow us on. It helps a lot. Forward this show to friends. Ways to subscribe to the American Conservative University Podcast Click here to subscribe via Apple Podcasts Click here to subscribe via RSS You can also subscribe via Stitcher FM Player Podcast Addict Tune-in Podcasts Pandora Look us up on Amazon Prime …And Many Other Podcast Aggregators and sites ACU on Twitter- https://twitter.com/AmerConU . Warning- Explicit and Violent video content.   Please help ACU by submitting your Show ideas. Email us at americanconservativeuniversity@americanconservativeuniversity.com   Endorsed Charities -------------------------------------------------------- Pre-Born! Saving babies and Souls. https://preborn.org/ OUR MISSION To glorify Jesus Christ by leading and equipping pregnancy clinics to save more babies and souls. WHAT WE DO Pre-Born! partners with life-affirming pregnancy clinics all across the nation. We are designed to strategically impact the abortion industry through the following initiatives:… -------------------------------------------------------- Help CSI Stamp Out Slavery In Sudan Join us in our effort to free over 350 slaves. Listeners to the Eric Metaxas Show will remember our annual effort to free Christians who have been enslaved for simply acknowledging Jesus Christ as their Savior. As we celebrate the birth of Christ this Christmas, join us in giving new life to brothers and sisters in Sudan who have enslaved as a result of their faith. https://csi-usa.org/metaxas   https://csi-usa.org/slavery/   Typical Aid for the Enslaved A ration of sorghum, a local nutrient-rich staple food A dairy goat A “Sack of Hope,” a survival kit containing essential items such as tarp for shelter, a cooking pan, a water canister, a mosquito net, a blanket, a handheld sickle, and fishing hooks. Release celebrations include prayer and gathering for a meal, and medical care for those in need. The CSI team provides comfort, encouragement, and a shoulder to lean on while they tell their stories and begin their new lives. Thank you for your compassion  Giving the Gift of Freedom and Hope to the Enslaved South Sudanese -------------------------------------------------------- Food For the Poor https://foodforthepoor.org/ Help us serve the poorest of the poor Food For The Poor began in 1982 in Jamaica. Today, our interdenominational Christian ministry serves the poor in primarily 17 countries throughout the Caribbean and Latin America. Thanks to our faithful donors, we are able to provide food, housing, healthcare, education, fresh water, emergency relief, micro-enterprise solutions and much more. We are proud to have fed millions of people and provided more than 15.7 billion dollars in aid. Our faith inspires us to be an organization built on compassion, and motivated by love. Our mission is to bring relief to the poorest of the poor in the countries where we serve. We strive to reflect God's unconditional love. It's a sacrificial love that embraces all people regardless of race or religion. We believe that we can show His love by serving the “least of these” on this earth as Christ challenged us to do in Matthew 25. We pray that by God's grace, and with your support, we can continue to bring relief to the suffering and hope to the hopeless.   Report on Food For the Poor by Charity Navigator https://www.charitynavigator.org/ein/592174510   -------------------------------------------------------- Disclaimer from ACU. We try to bring to our students and alumni the World's best Conservative thinkers. All views expressed belong solely to the author and not necessarily to ACU. In all issues and relations, we hope to follow the admonitions of Jesus Christ. While striving to expose, warn and contend with evil, we extend the love of God to all of his children. -----------------------------------------------------------------------------------------  American Conservative University A short survey to get to know our listeners! Thank you for listening :D https://docs.google.com/forms/d/e/1FAIpQLSfvB348iC85ZcAQCzgL8TX-5yf-o4IIT8e5thqRh1qZKVIkrg/viewform

Commentary by Dr. Douglas Mann and Dr. Daniel Burkhoff

FREEDOM - LIBERTY - HAPPINESS SUPPORT DOC MALIK To make sure you don't miss any episodes please subscribe to either: The paid Spotify subscription here: ⁠https://podcasters.spotify.com/pod/show/docmalik/subscribe The paid Substack subscription here: ⁠https://docmalik.substack.com/subscribe About this conversation: Professor Dolores Cahill was a Professor of Translational Science at UCD School of Medicine, University College Dublin. Dolores has over 25 years of expertise in high-throughput protein array, antibody array, proteomics technology development, automation and their biomedical applications, including in biomarker discovery, diagnostics and personalised medicine. Dolores has published over a hundred peer-reviewed research papers, and been invited to numerous international scientific meetings as a keynote speaker, however, the mainstream media simply describe her as "an anti-vaccine and anti-mask campaigner". The real Dolores Cahill is a Scientist, Immunologist, Inventor, Innovator and Fracking awesome Freedom Fighter. Dolores from the outset of the plandemic called out the scam and unscientific measures being introduced and warned of the dangers of the experimental gene modifying shots. In this conversation we talked about The Law, the fraudulent legal system and agents of the system that deny us all of our inalienable rights. I didn't know where this conversation was going to go, but I am so glad we had it. An incredible woman, intelligent and brave and prepared to lose it all to do the right thing. IMPORTANT NOTICE Following my cancellation for standing up for medical ethics and freedom, my surgical career has been ruined. I am now totally dependent on the support of my listeners, YOU. If you value my podcasts, please support the show so that I can continue to speak up by choosing one or both of the following options - ⁠Buy me a coffee⁠ If you want to make a one-off donation. Join my Substack To access additional content, you can upgrade to paid from just £5.50 a month Doc Malik Merch Store⁠ Check out my amazing freedom merch To sponsor the Doc Malik Podcast contact us at ⁠hello@docmalik.com⁠  About Doc Malik: Orthopaedic surgeon Ahmad Malik is on a journey of discovery when it comes to health and wellness. Through honest conversations with captivating individuals, Ahmad explores an array of topics that profoundly impact our well-being and health. You can follow us on social media, we are on the following platforms: ⁠Twitter Ahmad⁠ | ⁠Twitter Podcast⁠ | ⁠Instagram Ahmad⁠ | ⁠Instagram Podcast

For years, hot flashes and night sweats (aka vasomotor symptoms) were considered just a “bothersome” part of being a menopausal woman: we were to wear layers, buy a fan, and soldier on. Then researchers started making some troubling connections between vasomotor symptoms and chronic disease. This week's guest, Dr. Rebecca Thurston, is one of those investigators whose work shows that women with severe and/or persistent vasomotor symptoms have an increased risk for cardiovascular disease and changes in the brain that are linked to dementia. We dig into those findings and many more during this week's episode.Rebecca C. Thurston, PhD, FABMR, FAPS, is recognized nationally as a leader in the field of women's health, particularly in the areas of menopause, trauma, cardiovascular disease, and brain aging in women. Her innovative research focuses on menopause, cardiovascular disease, and dementia risk in women, three prevalent and inter-related health issues that can have a profound impact on women's lives. She is Pittsburgh Foundation Chair in Women's Health and Dementia and Professor of Psychiatry, Epidemiology, Psychology, and Clinical and Translational Science, at the University of Pittsburgh. She also serves as Director of Women's Biobehavioral Health Program at the University of Pittsburgh as well as Cardiovascular Behavioral Medicine Research Training Program at the University of Pittsburgh. You can learn more about her and her work at UPMC.com Resources:Trajectories of Sleep Over Midlife and Incident Cardiovascular Disease Events in the Study of Women's Health Across the Nation hereTrauma and its implications for women's cardiovascular health during the menopause transition: Lessons from MsHeart/MsBrain and SWAN studies hereMenopausal Vasomotor Symptoms and White Matter Hyperintensities in Midlife Women hereMenopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN hereCognitive behavioral therapy for insomnia hereBrief behavioral treatment for insomnia hereFollow Us on Instagram:Feisty Menopause: @feistymenopause Feisty Media: @feisty_media Selene: @fitchick3 Subscribe to the weekly Feisty Menopause blog: https://www.feistymenopause.com/feistyinbox Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099 Join Level Up - Our Community for Active Women Navigating the Menopause Transition:Join: https://www.feistymenopause.com/monthly-membership-1 Leave your questions for Selene:https://www.speakpipe.com/hitplay Get the Free Feisty Women's Guide to Lifting Heavy Sh*t:https://www.feistymenopause.com/liftheavy Support our Partners:Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/

Dr. Nora Disis (Medicine; Associate Dean for Translational Science; Director of the Institute of Translational Health Sciences and the UW Medicine Cancer Vaccine Institute) has carved her own path in becoming a woman with many leadership roles at UW Medicine. She tells the story of how she overcame adversities and followed her passions to make a huge impact in the field of cancer immunology and translational medicine. If you face resistance, Dr. Disis advises: stay true to your mission, reach out for additional opinions from experts in your field, and follow the data until you can secure additional funding and build your team. She provides strategy for evaluating risk in building your funding sources and encourages, above all, going for the gusto. Read the episode transcript here.Music by Kevin MacLeod (https://incompetech.com/)

Commentary by Dr. Douglas Mann and Dr. Elena Amin and Mr. Seth Wagner

Welcome to Episode 26 of The Oncology Podcast's Experts On Point series, brought to you by The Oncology Network. How can we change our inner worlds alongside our healthcare systems? How can we integrate trust and kindness into research projects? How can we build more equity into gastrointestinal cancer care?These were some of the innovative and fascinating topics discussed at the recent AGITG 2023 Annual Scientific Meeting held in Christchurch, Aotearoa, New Zealand.To review the meeting, our Host Rachael Babin is joined by the Co-Convenor Dr Ben Lawrence, Medical Oncologist practising in Auckland.  And international guest speaker, Associate Professor Katherine Garman, Vice Chief of Research in the Division of Gastroenterology at Duke University in Durham North Carolina, USA.We hope you enjoy listening.For news and podcast updates subscribe to The Oncology Newsletter,  a free weekly publication for healthcare professionals with an interest in oncology. Click here to subscribe.PART OF THE ONCOLOGY NETWORK... Join Us

After the international BIO 2023 convention wrapped up with Team Australia, MTPConnect took a tour of global biopharmaceutical company Sanofi's mRNA Centre of Excellence located in Greater Boston and learnt more about the company's plans for the Translational Science Hub being set up in Queensland in partnership with the Queensland Government, Griffith University, the University of Queensland. We catch up with Sanofi's Chief Technology Officer and Global Head of Research and Biomarkers at the mRNA Center of Excellence Frank DeRosa, and Sanofi's Global Head of Vaccine Research and Development Dr Jean-Francois Toussaint. As part of Sanofi's global research and development network, the Hub will initially focus on the evaluation of a new generation of mRNA vaccines, the development of a world-first chlamydia vaccine, building Australian biomanufacturing capabilities in Brisbane and connecting into the biomedical ecosystem.

References Alzheimer's Research & Therapy 2021. volume13, Article number: 56. Progress in Molecular Biology and Translational Science 2019. Volume 168 # --- Send in a voice message: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/message Support this podcast: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/support

This episode of Lung Cancer Considered previews the upcoming IASLC Hot Topic in Basic and Translational Science Meeting on Resistance to Immunotherapy in NSCLC. Joining host Dr. Stephen Liu are: Guests: Dr. Joachim Aerts, Professor of Pulmonary Oncology at Erasmus University Rotterdam and Head of Pulmonary Medicine at Erasmus MC in the Netherlands. Dr. Kellie Smith, Associate Professor of Oncology at Johns Hopkins University. Dr. Roberto Ferrara, Medical Oncologist and Immunologist, from Istituto Nazionale dei Tumori di Milano in Milan, Italy.

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Herbert L. Bonkovsky, MD If an elevation of delta aminolevulinic or porphobilinogen occurs in the urine more than three times what is normal, that is presumptive acute hepatic porphyria (AHP. Join the conversation as Dr. Peter Buch speaks with Dr. Herbert Bonkovsky, Professor of Medicine and Molecular Medicine and Translational Science at Wake Forest University, about his article published in Gastroenterology.

A review of current literature around magic mushrooms for nicotine and alcohol dependency, end of life therapy, and more. Notes: Per Christopher Toney, a reminder that psilocybin dosing is based on dry weight of the whole mushrooms, for those curious about how dosing is calculated. How well does this approximate actual psilocybin content? This will be a good future topic for discussion. References: Link to FDA's Considerations for Clinical Investigations of Psychedelic Drugs (Accessed 11 July 2023): https://www.fda.gov/regulatory-information/search-fda-guidance-documents/psychedelic-drugs-considerations-clinical-investigations.   Bogenschutz MP, et al. Percentage of heavy drinking days following psilocybin assisted psychotherapy vs placebo in the treatment of patients with alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2022; 79(10): 953-962 https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2795625 Carhart-Harris R, et al. Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine. 2021: 384: 1402-1411. https://www.nejm.org/doi/full/10.1056/nejmoa2032994 Ebbesen-Jensen M, et al. Psilocybin assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomized, double blinded, placebo controlled 12 week clinical trial (the QUANTUM trip trial). BMJ Open. 2022; 12(10). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577917/ Ercolano, A. (2023) Johns Hopkins Center for psychedelic and Consciousness Research, Johns Hopkins Medicine. Available at: https://www.hopkinsmedicine.org/psychiatry/research/psychedelics-research.html Fauber J and Fiore K. Slippery slope: Fen-Phen users recall a “miracle” turned nightmare. Milwaukee Journal Sentinel/Med Page Today. 19 April 2015. https://www.medpagetoday.com/special-reports/slipperyslope/51044 Goodwin GM, et al. Single dose psilocybin for treatment for a treatment resistant episode of major depression. New England Journal of Medicine. 2022; 387(18). https://www.nejm.org/doi/pdf/10.1056/NEJMoa2206443?articleTools=true Griffiths RR, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double blind trial. Journal of Psychopharmacology. 2016; 30(2): 1181-1197 Grob CS, et al. Pilot study of psilocybin for anxiety in patients with advanced stage cancer. JAMA Psychiatry. 2011; 68(1): 71-78. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/210962 Kenney A. What to know about Colorado's psychedelic law. Colorado Public Radio. 21 June 2023. https://www.cpr.org/2023/06/21/colorado-psychedelic-law-for-psilocybin-mushrooms/ Rosenbaum D, et al. Psychedelics for existential distress in palliative and cancer care. Current Oncology. 2019; 26(4): 225-226. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726261/ Ross S, et al. Acute and sustained reductions in loss of meaning and suicidal ideation following psilocybin-assisted psychotherapy for psychiatric and existential distress in life threatening cancer. ACS Pharmacology and Translational Science. 2021; 4(2): 553-562. https://pubmed.ncbi.nlm.nih.gov/33860185/ Rotz VR, et al. Single dose psilocybin assisted therapy in major depressive disorder: a placebo controlled, randomized double blind trial. The Lancet. 2023;56: 101809. https://www.thelancet.com/action/showPdf?pii=S2589-5370%2822%2900538-7   To read about “Mad Honey” that we referenced towards the end of the podcast: see here: https://bigthink.com/health/mad-honey/#:~:text=But%20what%20really%20distinguishes%20mad,%2C%20in%20rare%20cases%2C%20death.

Medicines safety monitoring is a continuous process that begins with pre-marketing clinical trials and continues with post-marketing studies to fill any gaps in knowledge. With Marianne Lunzer from AGES and Sanja Prpić from HALMED, we review the pros and cons of various study types and the importance of testing medicines on diverse populations.Tune in to find out:How pre- and post-approval safety studies are connectedWhy safety assessors can request studies in underrepresented populationsHow new regulations are impacting safety assessments in the EUWant to know more?This review in Trials summarises the methodological challenges of assessing drug safety in clinical trials, while this study in Clinical and Translational Science reviews how sex, racial, and ethnic diversity in clinical trials have changed in recent years. Post-authorisation safety studies can be imposed or voluntary and can be carried out as clinical trials or as non-interventional studies. Read about the differences on the European Medicines Agency's website.Large simple trials can control for biases in observational research while still providing results that are generalisable to real-world use. This review in Drug Safety explains why.The new Clinical Trials Regulation harmonises how EU trials are assessed and supervised for increased safety and transparency. As part of these efforts, the SAFE CT project aims to facilitate clinical trial coordination and safety assessments in the EU.For more on clinical trials, revisit this conversation with Peter Doshi on restoring invisible and abandoned trials.This episode is the last of a three-part series on sources of evidence in pharmacovigilance. Listen to the first two episodes here:The evidence for signalsUnlocking the power of real-world dataJoin the conversation on social mediaFollow us on Twitter, Facebook or LinkedIn and share your thoughts about the show with the hashtag #DrugSafetyMatters.Got a story to share?We're always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!About UMCRead more about Uppsala Monitoring Centre and how we work to advance medicines safety.

The launch of the Simpson Querrey Lung Institute for Translational Science (SQLIFTS) at Northwestern University Feinberg School of Medicine aims to expedite the discovery and implementation of innovative lung disease treatments through a patient-centered approach. In this episode, Scott Budinger, MD, the new executive director of the institute, discusses its launch and how it aims to transform lung disease research and clinical care.   

On episode 423 of The Nurse Keith Show nursing and healthcare career podcast, Keith interviews Dr. Jing Wang, PhD, MPH, RN, FAAN, Dean and Professor of the Florida State University College of Nursing, and Adjunct Professor in Biomedical Informatics and Public Health at the University of Texas Health Science Center at Houston. In the course of their conversation, Keith and Dr. Wang discuss the future of health and healthcare and how Florida State University College of Nursing is leading in this area. Other topics include the future of aging in place, the use of wearable tech, and the concept of a “high tech high touch” approach to nursing research and education. Jing Wang, PhD, MPH, RN, FAAN is Dean and Professor of the Florida State University College of Nursing, and Adjunct Professor in Biomedical Informatics and Public Health at the University of Texas Health Science Center at Houston. She serves as the Board of Trustee at the Robert Wood Johnson Foundation and HCA Florida Capitol Hospital. She's committed to nursing workforce development and High Tech High Touch approach in nursing education, research, and collaborative practice. Her interdisciplinary research uses mobile and connected health technologies to optimize multiple-behavior lifestyle interventions and improve patient-centered outcomes among the chronically ill and aging populations with multiple chronic conditions, especially among the rural and underserved populations. Dr. Wang is an elected Fellow of the American Academy of Nursing, 2013 Robert Wood Johnson Foundation Nurse Faculty Scholar, 2015 TEDMED Scholar, 2016 Josiah Macy Jr. Foundation Macy Faculty Scholar, and Harvard Macy Scholar where she continues to teach in the “Leading Innovations in Health Care & Education” program in the Harvard Macy Institute. As a Health and Aging Policy Fellow and American Political Science Association Congressional Fellow, she was a Senior Scientific Advisor to Agency for Healthcare Research and Quality (AHRQ), and works with Centers for Medicare & Medicaid Services (CMS) and the Office of the National Coordinator for Health Information Technology (ONC) as a senior policy advisor. Wang received her MSN and PhD from the University of Pittsburgh School of Nursing, her MPH from its Graduate School of Public Health, and Graduate Certificate in Clinical and Translational Science from its School of Medicine. Connect with Dr. Jing Wang and Florida State University School of Nursing: Florida State University College of Nursing Facebook Instagram Twitter LinkedIn Dr. Wang on LinkedIn ----------- Did you know that you can now earn CEUs from listening to podcasts? That's right — over at RNegade.pro, they're building a library of nursing podcasts offering continuing education credits, including episodes of The Nurse Keith Show! So just head over to RNegade.pro, log into the portal, select Nurse Keith (or any other Content Creator) from the Content Creator dropdown, and get CEs for any content on the platform! Nurse Keith is a holistic career coach for nurses, professional podcaster, published author, award-winning blogger, inspiring keynote speaker, and successful nurse entrepreneur. Connect with Nurse Keith at NurseKeith.com, and on Twitter, Facebook, LinkedIn, and Instagram. Nurse Keith lives in beautiful Santa Fe, New Mexico with his lovely fiancée, Shada McKenzie, a highly gifted traditional astrologer and reader of the tarot. You can find Shada at The Circle and the Dot. The Nurse Keith Show is a proud member of The Health Podcast Network, one of the largest and fastest-growing collections of authoritative, high-quality podcasts taking on the tough topics in health and care with empathy, expertise, and a commitment to excellence. The podcast is adroitly produced by Rob Johnston of 520R Podcasting, and Mark Capispisan is our stalwart social media manager and newsletter wrangler.

Commentary by Dr. Douglas Mann and Joe Passman, Alexander Rothman and Abu Khalifa

Commentary by Dr. Douglas Mann and Dr. Daniel Burkhoff

In this episode, we sit down with Dr. Colleen A. McClung, a Professor of Psychiatry and Clinical and Translational Science at the University of Pittsburgh. She is also the Director of the NIDA-funded Center for Adolescent Reward, Rhythms, and Sleep – a translational center dedicated to understanding the contribution of sleep and circadian disruptions to addiction vulnerability in adolescents. As a renowned leader in her field, Dr. McClung focuses her research on the molecular mechanisms of bipolar disorder, major depression, and drug addiction. By studying the interconnectivity between these psychiatric disorders and the circadian clock, Dr. McClung has made many fascinating discoveries – some you may never have guessed… Join in now to find out: What the body's “molecular clock” is made up of. The two major processes that control sleep.  What happens to your brain when you fall asleep. Factors that can negatively affect your circadian rhythm. To learn more about Dr. McClung and her research, click here now! Episode also available on Apple Podcasts: http://apple.co/30PvU9C

In this episode of Deserts to Mountaintops, Jessica interviews Cameron Curtis, author of the anthology chapter titled "The Sound of Resilience,"  where she details her desert to mountaintop experience. Deserts to Mountaintops is a limited series podcast created by Top 1% ranking podcast host, Jessica Kidwell, she lifts the author off the page as she holds conversations with co-authors of this inaugural anthology released in January 2023 by Soul Speak Press.This series is meant to give readers of DTM a deeper insight into the authors that brought their experiences to the page and hopes to inspire it's audience to a place of transformational healing.Deserts to Mountaintops: Our Collective Journey to (re)Claiming Our Voice is available now on Amazon.For more information on Deserts to Mountaintops, Soul Speak Press and upcoming anthologies, please visit www.desertstomountaintops.com.  For more information Jessica Buchanan, please visit www.jessbuchanan.com or follow her on instagram at @jessicacbuchananMeet Cameron: Cameron Curtis is a classically trained musician. Was. Cameron's passion for music, beginning with piano and then vocal performance, began in middle school throughcollege where she graduated with a Bachelor of Arts with a concentration in musical theater and opera. It stops there. She met the love of her life, Scott, got married, moved to Northern Virginia, and bought a house at the age of 23.She lost her voice. Cameron's family life has always been solid. Her mother andfather gave her unconditional love and support regardless of the path she took. Both encouraged her to be authentic and strong. She had two strong-willed grandmothers who impressed upon her from an early age that you should always take advantage of opportunities, even if they seemed risky. Following that advice, she took a job as an executive assistant for a higher-education not-for-profit. From there she movedher way up the ladder from meeting planning to CEO. She discovered her true voice. Cameron is currently the President & CEO of C2 Association Strategies and has more than twenty-two years of not-for-profit management experience. She's led organizations such as the Association for Air Medical Services, MedEvacFoundation International, Society of Interventional Oncology, Association for Clinical and Translational Science, and the Texas Speech-Language Hearing Association. In addition, Cameron provided oversight for meetings and events, domestically and internationally. Cameron's passion for growing leaders and helping others find their voices shows in her willingness to take advantage of any opportunity that comes her way. Risk is exciting to her, and she lives by the mantra her grandmother taught her,“Never turn down anything but your coat collar.” Follow along on her website at www.c2associationstrategies.com or on Instagram and LinkedIn @cunzcurtis and Facebook at C2 Association Strategies.The theme song is courtesy of the The Mystic Chics.Instagram @themysticchics

Hosts: Jake Lancaster MD, Chief Medical Information Officer and Amanda Comer DNP, System Director, Advanced Practice ProvidersGuest: Christa George Pharm-D, Associate Professor of Clinical Pharmacy and Translational Science at the UT Health Science CenterCME Credit Info:Link to complete brief survey and claim CME credit: https://www.surveymonkey.com/r/C55LKSYCME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

How does learning really work? Who better to join us on the podcast than Dr. Marie K. Norman -- the co-author of “How Learning Works: 8 Research Based Principles of Smart Teaching,” to answer the question? After graduating from University of Pittsburgh and acquiring her Ph.D, Dr. Norman began teaching at Carnegie Melon and has been there for 14 years, including designing programs for the Eberly Center for Teaching Excellence. More recently she's moved back to her alma mater as an associate professor of Medicine, Clinical and Translational Science, as well as the Director of the university's Innovative Design for Education and Assessment (IDEA) Lab, where her research focuses on everything from the application of research-based learning principles to teaching to cross-cultural issues in education. We had a great time sitting down with Dr. Norman, where we chatted about exactly how learning works, what generative learning is, why it's so effective, why both challenge and engaging content is so important, and what new updates are being made to the newest edition to “How Learning Works: 8 Research Based Principles for Smart Teaching.” You want to build a high performance workforce? You aren't going to want to miss this episode...

This episode is a rebroadcasting of a DIGA webinar with Dr. Feldman: Dr. Steven R. Feldman is Professor of Dermatology, Pathology, Social Sciences & Health Policy, and Molecular Medicine & Translational Science at the Wake Forest School of Medicine. He received MD and PhD degrees from Duke University and completed dermatology residency at the University of North Carolina at Chapel Hill and dermatopathology training at the Medical University of South Carolina. He leads the Center for Dermatology Research, a health services research center whose mission is to improve the care of patients with skin disease. Dr. Feldman's chief clinical interest is psoriasis, a chronic, physically & psychosocially disabling condition. His passion is to help guide how patients with psoriasis are treated. He serves on the Medical Board of the National Psoriasis Foundation and directed psoriasis education programs for the American Academy of Dermatology. According to Expertscape.com, Feldman has been rated among the top experts in the world on psoriasis, acne and dermatology. Music: District Four by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3662-district-four License: https://filmmusic.io/standard-license --- Send in a voice message: https://podcasters.spotify.com/pod/show/derminterest/message

In April 2020, Gov. Whitmer assembled a taskforce to target biases and barriers that have long prevented racial minorities from receiving adequate medical care; something that was made abundantly clear during the early weeks of the pandemic. The Michigan Coronavirus Task Force on Racial Disparities was called to identify and help reduce the disparities in COVID cases. GUESTS: Dr. Phil Levy, Associate Vice President of Translational Science at Wayne State University; Director of the Center for Population Health Accountability at Wayne Health Dr. Renee Canady, CEO of the Michigan Public Health Institute ____ Looking for more conversations from Stateside? Right this way. If you like what you hear on the pod, consider supporting our work. Music in this episode by Blue Dot Sessions.See omnystudio.com/listener for privacy information.

From microphysiological systems and digital pathology to next-generation-sequencing and diversity in foundational genomic data sets: In this iteration of our annual year in review podcast, Global Forum Co-Editors for Translational Science Gary Kelloff and Lanny Kirsch discuss emergent technologies and approaches that are upending clinical development, diagnostic, and patient care in oncology and beyond.

Season 2 | Episode 39 | September 28, 2022Stephen T. Higgins, PhD, a national leader in addiction research and the director of the Vermont Center on Behavior & Health (VCBH) at the University of Vermont (UVM) is the guest on Medical Matters Weekly with Dr. Trey Dobson on September 28.Dr. Higgins is principle investigator on multiple National Institutes of Health grants on the general topic of behavior and health, including a National Institute of General Medical Sciences' Center for Biomedical Research Excellence (COBRE) award, a National Institute of Drug Abuse (NIDA)/Food and Drug Administration's Tobacco Centers of Regulatory Science (TCORS) award, and a NIDA institutional training award. He is the Virginia H. Donaldson Endowed Professor of Translational Science in the departments of psychiatry and psychological science at UVM and serves as vice chair of psychiatry.Dr. Higgins' research centers around behavioral economics and behavioral pharmacology to investigate tobacco, substance use, and other health-related risk behaviors in vulnerable populations. His projects focus on examining mechanisms underpinning vulnerability to tobacco and other risk behaviors, treatment interventions to reduce them and improve health outcomes, and regulatory science. He is the author of more than 425 journal articles and invited book chapters and editor of a dozen volumes and therapist manuals in behavior and health.VCBH is an interdisciplinary research center committed to investigating relationships between personal behavior patterns (i.e., lifestyle) and risk for chronic disease and premature death. Their work has historically focused on health disparities for the most vulnerable populations, particularly among the socioeconomically disadvantaged where these risk factors are overrepresented.Medical Matters Weekly features the innovative personalities who drive positive change within health care and related professions. The show addresses all aspects of creating and maintaining a healthy lifestyle for all, including food and nutrition, housing, diversity and inclusion, groundbreaking medical care, exercise, mental health, the environment, research, and government. The show is produced with cooperation from Catamount Access Television (CAT-TV). Viewers can see Medical Matters Weekly on Facebook at facebook.com/svmedicalcenter and facebook.com/CATTVBennington. The show is also available to view or download a podcast on www.svhealthcare.org/medicalmatters.Underwriter: Mack Molding

Today we connect with Dr. Noelle Patno, a microbiome scientific educator that has cultivated a distinct approach to nutritional research. Dr. Patno has a Ph.D. in Molecular Metabolism and Nutrition, and a Master's in Translational Science from the University of Chicago. Utilizing her years of education and experience, she is on a mission to “advance effective and safe therapies for patients facing difficult healthcare decisions.” Dr. Patno has dealt with her share of health difficulties, and this has played a major role in informing her approach to wellness and medicine. Most recently, she has focused her research on nutritional ingredients – primarily in probiotics and the microbiome. Offer: Increased stress is linked with teeth grinding and clenching, which causes poor sleep, jaw pain and headaches. But did you know that 1 in every 4 adults grind or clench their teeth while sleeping? A Remi Custom Night Guard can protect your teeth from grinding and clenching while saving you hundreds of dollars compared to the dental office. Use code GUARD20 for 20% off your order. Visit ShopRemi.com now. Click play now to explore: Dr. Patno's studies regarding the gastrointestinal system. The factors that influence peoples' response to prebiotics and fiber. The importance of affecting the overall diversity of gut bacteria when it comes to intestinal health.  The human digestive system is incredibly complex and affects so many other parts of the body. Want to know more about what researchers like Dr. Patno are doing to uncover solutions to gut health problems? Join us in this episode to find out! To learn more about Dr. Patno and her work, visit linkedin.com/noelle-patno-phd now! Episode also available on Apple Podcast: http://apple.co/30PvU9C

Introduction of moderator, faculty, and disclosures by Todd: ­We have an incredible discussion coming up with our moderator, Dr. Jessica Kerr, Professor and Clinical Pharmacy Specialist – Cardiometabolic at the Southern Illinois University Edwardsville School of Pharmacy in Illinois and Dr. Joanna Hudson, who is a tenured Professor in the Department of Clinical Pharmacy and Translational Science and the Department of Medicine (Division of Nephrology) at the University of Tennessee (UT) Health Science Center and a Clinical Pharmacist specializing in nephrology at Methodist Hospital in Memphis, TN. They will provide a brief overview of anemia in chronic kidney disease and highlight updates and advancements in the development of some of the emerging agents used.  If you haven't listened to the three other webinars in this learning series on anemia in chronic kidney disease, be sure to check them out at pharmacytimes.org. Outline updates and advancements in the development of HIF-PH inhibitors for anemia in chronic kidney disease.   Express the role of the pharmacist in managing anemia in CKD through early detection and coordination of care.    Guests:    Dr. Jessica Kerr PharmD Interim Associate Dean - Office of Professional and Student Affairs at Southern Illinois University Edwardsville   Dr. Joanna Hudson PharmD Professor at University of Tennessee Health Science Center Learn more about your ad choices. Visit megaphone.fm/adchoices

Cocoa may enhance skeletal muscle function University of California at San Diego, May 3, 2022 A small clinical trial led by researchers at UC San Diego School of Medicine and VA San Diego Healthcare System (VASDHS) found that patients with advanced heart failure and type 2 diabetes showed improved mitochondrial structure after three months of treatment with epicatechin-enriched cocoa. Epicatechin is a flavonoid found in dark chocolate. The study published by the journal Clinical and Translational Science looked at profoundly ill patients with major damage to skeletal muscle mitochondria. The trial participants consumed dark chocolate bars and a beverage with a total epicatechin content of approximately 100 mg per day for three months. Biopsies of skeletal muscle were conducted before and after treatment. After the three-month treatment, the researchers looked at changes in mitochondria volume and the abundance of cristae, which are internal compartments of mitochondria that are necessary for efficient function of the mitochondria, and measurable by electron microscopy. After three months, we saw recovery – cristae numbers back toward normal levels, and increases in several molecular indicators involved in new mitochondria production.” Healthy habits may improve longevity, prevent Alzheimer's disease Rush University Medical Center, May 14, 2022 Everyday habits that serve as the backbone of a healthy lifestyle may keep your brain sharp and help you live longer, according to new research from aging experts at RUSH. A study recently published in the British Medical Journal found that people ages 65 and older who had a healthy lifestyle lived longer—3.1 years longer for women, 5.7 years longer for men—than their peers who didn't have the same healthy lifestyle. They also spent more of their remaining years without Alzheimer's disease. What constitutes a healthy lifestyle?Eating the Mediterranean-DASH Intervention for Neurogenerative Delay (MIND) diet Staying engaged in cognitive activities like reading and puzzles Being physically active for at least 150 minutes a week Not smoking Limiting alcohol use (no more than one drink a day for women and two drinks a day for men) This latest study builds on ongoing research from RUSH showing that lifestyle factors can potentially reduce the risk for Alzheimer's disease and dementia by up to 60%, says Kumar Rajan, Ph.D., professor of epidemiology and director of the Rush Institute for Healthy Aging. Ozone treated water v. lethal microbial material   University of Alberta,  May 9, 2022 A University of Alberta research team has discovered that technology commonly used to decontaminate food industry equipment can also rid meat processing plants of lethal microbial material responsible for the human version of the ailment Mad Cow disease. U of A microbiology professors Mike Belosevic and Norm Neumann and engineering professor Mohamed Gamal El-Din demonstrated that infectious proteins found in the brain matter of cattle can be eradicated from water treated with ozone. The discovery could have applications in decontaminating wastewater in settings such as slaughterhouse effluents where infected neural material known as prions may be present. The ozone decontamination procedure can potentially be used to sterilize instruments used for neurosurgery, and prevent the transfer of infectious prions during surgical procedures. Prions are able to destroy and can still be infectious after being incinerated at heats of 850o C. In the wild, soil contaminated by a carcass of a deer that died of Chronic Wasting Disease can remain a source of infection for many years. The U of A research team's technique of using water treated with ozone to destroy prions is an improvement on current prion decontamination methods. Tai Chi Benefits Patients With Parkinson's Oregon Research Institute, May 13, 2022 Tai chi, an ancient martial art characterized by slow, flowing movement and meditation, helps improve balance and movement control for people with Parkinson's disease. The finding, published in The New England Journal of Medicine, is the latest study to show the benefits of tai chi for people with chronic health problems. Past studies have shown that tai chi reduces falls and depression among the elderly, and lessens pain for patients with arthritis and fibromyalgia. In the latest research, 195 people with movement and balance problems caused by Parkinson's disease were recruited from four Oregon cities. The patients were divided into three exercise classes that met for an hour a day, twice a week. One group took part in an extensive stretching class, another was taught resistance training, and the third group performed tai chi. After six months, patients in the tai chi group performed better on a number of measures related to strength, movement control, balance, stride length and reach. Resistance training also offered some benefits, and both the tai chi and resistance training groups had fewer falls than the stretching group. Vitamin B12 shows promise against ALS Tokushima University (Japan), May 13 2022.  An article appearing on May 9, 2022 in JAMA Neurology described a randomized trial in which men and women with the progressive neurologic disease amyotrophic lateral sclerosis (ALS) exhibited improvement in their condition after receiving a high dose of a form of vitamin B12 known as methylcobalamin.  Among the 126 patients who completed the trial, Amyotrophic Lateral Sclerosis Functional Rating Scale  scores declined by an average of 2.66 points for those who received the vitamin and by 4.63 in the placebo group—a difference of 43%. (Lower scores indicate increased severity of symptoms.)  This randomized clinical trial demonstrated that use of ultrahigh-dose methylcobalamin resulted in a 43% reduction in clinical deterioration as evaluated with the ALSFRS-R total score throughout the 16-week treatment period in the patients with early-stage ALS, Diabetes risk from sitting around University of Leicester (UK), May 12, 2022 A new study has found that women who stay seated for long periods of time every day are more prone to developing type 2 diabetes, but that a similar link wasn't found in men. Researchers from the University of Leicester Departments of Health Sciences and Cardiovascular Sciences revealed that women who are sedentary for most of the day were at a greater risk from exhibiting the early metabolic defects that act as a precursor to developing type 2 diabetes than people who tend to sit less. The team assessed over 500 men and women of the age of 40 or more about the amount of time spent sitting over the course of a week. It was found that the women who spent the longest time sitting had higher levels of insulin, as well as higher amounts of C-reactive protein and chemicals released by fatty tissue in the abdomen, leptin, and interleukin6, and which indicate problematic inflammation. This study provides important new evidence that higher levels of sitting time have a deleterious impact on insulin resistance and chronic low-grade inflammation in women but not men and that this effect is seen regardless of how much exercise is undertaken. This suggests that women who meet the national recommendations of 30 minutes of exercise a day may still be compromising their health if they are seated for the rest of the day. Videos: 1. Fauci Clip Surfaces, As Incoherent In 1985 As He Is Now: Spreads Diabolical Lie That “HIV” Could Spread To Children Via Casual Contact In Household (0:35) 2. Margaret Heckler & Robert Gallo – 1984 Press Conference (0:38) 3. Melissa Ciummei Clip  (9:52) 4. A terrifying prediction for 2030 (the Great Reset) (start @ 1:12) 5. New Rule: American Carnage | Real Time with Bill Maher (HBO) (7:48)